Home › Atrial Fibrillation › Arizona › Phoenix
Atrial Fibrillation clinical trials in Phoenix, AZ
5 studies for Atrial Fibrillation are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- Banner University, Phoenix
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Recruiting
- Phoenix Cardiovascular Research Group, Phoenix
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Recruiting
- Banner University Med Ctr, Phoenix
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
RecruitingPhase 3
- Anthos Investigative Site 9906, Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
RecruitingPhase 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- New York City, NY21 studies
- Boston, MA17 studies
- Cleveland, OH17 studies
- Atlanta, GA16 studies
- Jonesboro, AR12 studies
- Philadelphia, PA12 studies
- Chicago, IL12 studies
- Ann Arbor, MI11 studies
- Columbus, OH10 studies
- Cincinnati, OH10 studies
- Pittsburgh, PA10 studies
- Austin, TX9 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity22 studies
- Non-Small Cell Lung Cancer20 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Multiple Myeloma16 studies
- Pancreatic Cancer16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.